Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.92 USD | -2.97% | +1.82% | -31.35% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 42.29M | Sales 2025 * | 52.34M | Capitalization | 1.15B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -215M | EV / Sales 2024 * | 24.4 x |
Net cash position 2024 * | 120M | Net cash position 2025 * | 2M | EV / Sales 2025 * | 22 x |
P/E ratio 2024 * |
-6.85
x | P/E ratio 2025 * |
-6.37
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.02% |
Latest transcript on AbCellera Biologics Inc.
1 day | -2.97% | ||
1 week | +1.82% | ||
1 month | +3.70% | ||
3 months | -22.38% | ||
6 months | -16.77% | ||
Current year | -31.35% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 12-11-07 | |
Founder | - | 12-11-07 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 20-10-31 |
Michael Hayden
BRD | Director/Board Member | 72 | 19-09-30 |
Andrew Lo
BRD | Director/Board Member | 63 | 21-12-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 0 M€ | 0.00% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.92 | -2.97% | 1,082,677 |
24-05-30 | 4.04 | -0.98% | 895,159 |
24-05-29 | 4.08 | -.--% | 1,596,096 |
24-05-28 | 4.08 | +5.97% | 2,888,465 |
24-05-24 | 3.85 | -.--% | 1,047,467 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.35% | 1.15B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ABCL Stock